Enhancing Nrf2 By Sulforaphane Improves Glucocorticosteroid Responses In COPD

Rajesh K. Thimmulappa; Deepti Malhotra; Nicolas Mercado; Kazuhiro Ito; David Feller‐Kopman; Peter J Barnes; Robert A. Wise; Shyam Biswal

doi:10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a2272

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Retracted Article2014

Denitrosylation of HDAC2 by targeting Nrf2 restores glucocorticosteroid sensitivity in macrophages from COPD patients

Deepti Malhotra, Rajesh K. Thimmulappa, Nicolas Mercado, Kazuhiro Ito, Ponvijay Kombairaju, Sarvesh Kumar, Jinfang Ma, David Feller‐Kopman, Robert A. Wise, Peter J Barnes, Shyam Biswal

Article2011

Denitrosylation of HDAC2 by targeting Nrf2 restores glucocorticosteroid sensitivity in macrophages from COPD patients

Deepti Malhotra, Rajesh K. Thimmulappa, Nicolas Mercado, Kazuhiro Ito, Ponvijay Kombairaju, Sarvesh Kumar, Jinfang Ma, David Feller‐Kopman, Robert A. Wise, Peter J Barnes, Shyam Biswal

Article2014

The anti-inflammatory effects of sulforaphane are not mediated by the Nrf2 pathway

Andrew Durham, Elen Jazrawi, Jo Ann Rhodes, Cara Williams, Ian Kilty, Peter J Barnes, Kang‐Hyun Chung, Ian M. Adcock

Article2017

Inhibition of dynein motors improves macrophage phagocytosis in COPD

Katie L. Anders, Kylie Belchamber, Peter J Barnes, Louise Donnelly

Article2015

Elevated CCL2 responses in COPD and attenuation by selective chemokine receptor antagonists

Ceri Davies, Jo Ann Rhodes, Peter J Barnes, Louise Donnelly